ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Acer Therapeutics Plans Clinical Trial for Edsivo (celiprolol) Following Type B FDA Meeting
June 21, 2021Acer Therapeutics Inc. today announced that following a recent Type B meeting with the U.S. Food and Drug Administration (FDA) regarding Acer’s proposed Edsivo™ (celiprolol) development plan -
Acer Therapeutics, NCATS partner to develop emetine for Covid-19
May 14, 2020Pharmaceutical company Acer Therapeutics has partnered with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride for the potential treatment of Covid-19 patients. -
Sanofi offloads drug programmes to MyoKardia and Acer Therapeutics
January 04, 2019Sanofi has returned worldwide rights to all programmes that were covered under a licence and collaboration agreement signed with biopharmaceutical company MyoKardia in 2014.
Pharma Sources Insight January 2025
